Company profile

UltraSight

Medical Imaging & Radiology

Company profile

About UltraSight

UltraSight is a digital health pioneer transforming cardiac imaging through the power of artificial intelligence. The company's real-time AI guidance software enables medical professionals without sonography experience to acquire diagnostic-quality cardiac ultrasound images across multiple care settings, including emergency departments, clinics, community hospitals, ambulances, and remote areas. The platform pairs with point-of-care ultrasound devices and provides a graphic interface overlaid on the ultrasound screen, guiding users in real-time on how to maneuver the probe to obtain diagnostic quality images. UltraSight's technology addresses a critical healthcare gap: while over 8 million patients are admitted to U.S. emergency departments annually with symptoms concerning for heart attack or heart failure, and approximately 30 million heart disease patients require periodic cardiac monitoring, significant bottlenecks and limited training resources restrict access to timely cardiac ultrasound. The company's AI neural network predicts the position of the ultrasound probe relative to the heart based on the ultrasound video stream, providing three-dimensional guidance with precise magnitude of movement. Clinical studies demonstrate that after minimal training with the AI guidance software, novice users can acquire images of diagnostic quality approaching that of expert sonographers in 93-100% of patient exams. UltraSight has received FDA clearance and CE Marking, enabling deployment across healthcare systems, emergency medicine, out-of-hospital care, and critical care settings.

Company description UltraSight official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at UltraSight?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Cardiac monitoring
  • Heart attack
  • Heart disease
  • Heart failure
  • Left ventricular function
  • Pericardial effusion
  • Right ventricular size

Who it serves

  • Ambulance services
  • Clinics
  • Community Hospitals
  • Critical Care units
  • Emergency Departments
  • Health Systems
  • Out-of-hospital care providers

Deployment & integration

Embedded deployment with recorded integration context.

Recorded integration context: Philips Lumify Ultrasound System.

Geographic context

MarketsEuropean Union · Israel · United Kingdom · United States
Company sourceOfficial website

Company milestones

Platform expansion

FDA clearance granted July 2023. Expanded FDA clearance received to work across ultrasound systems. New data presented at ACC 2025 and THT 2026. PVAD IQ product for critical care launched. Seeking clinical researchers for investigator-led research grants.

Partnerships

Recorded partners

  • Aurora St. Luke's Medical Center
  • Bristol Myers Squibb
  • Philips (Lumify Ultrasound System)
  • Sheba Medical Center
  • University of Chicago

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

UltraSight AI Guidance

AI-powered real-time guidance software for cardiac ultrasound image acquisition

Software · EmbeddedCompany source

UltraSight PVAD IQ

AI-enabled imaging tool for bedside pump position assessment in critical care

Software · EmbeddedCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

99.2% diagnostic quality for LV size assessment

Pivotal study results

99.6% diagnostic quality for LV function assessment

Pivotal study results

92.9% diagnostic quality for RV size assessment

Pivotal study results

100% diagnostic quality for pericardial effusion assessment

Pivotal study results

93-100% diagnostic quality exams by novice users

Overall pivotal study performance

Aurora St. Luke's Medical Center

Multicenter pivotal study location for evaluating UltraSight AI guidance software in enabling non-experts to perform echocardiographic examinations

Demonstrated that novice users can acquire images of diagnostic quality approaching that of expert sonographers in the majority of patients

Sheba Medical Center

Multicenter pivotal study location in Israel for validating UltraSight's real-time guidance technology for cardiac ultrasound

Clinical interpretation was similar when exams were done by novice users using UltraSight's Real-Time Guidance software compared with sonographers

University of Chicago

Multicenter pivotal study to evaluate AI guidance software's ability to enable medical professionals without echocardiography experience to acquire cardiac ultrasound images

Medical professionals without prior sonography experience acquired high quality diagnostic images in 93-100% of patient exams, with 99.2% sufficient quality for LV size, 99.6% for LV function, 92.9% for RV size, and 100% for pericardial effusion

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Roberto Lang

Director of Cardiovascular Imaging (Clinical Advisor)

06 · Company updates

Updates from UltraSight

Recent articles published on UltraSight's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon